Home > Income Statement > NATCO PHARMA

NATCO PHARMA
Revenue

    Back to Income Statement
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹4,430 Cr₹3,999 Cr₹2,707 Cr₹1,945 Cr₹2,052 Cr

What is the latest Revenue of NATCO PHARMA ?

The latest Revenue ratio of NATCO PHARMA is ₹4,430 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹4,430 Cr
Mar2025₹3,999 Cr
Mar2024₹2,707 Cr
Mar2023₹1,945 Cr
Mar2022₹2,052 Cr

How is Revenue of NATCO PHARMA Trending?

Years Revenue % Change
Mar2026 ₹4,430 Cr
10.77
Mar2025 ₹3,999 Cr
47.72
Mar2024 ₹2,707 Cr
39.20
Mar2023 ₹1,945 Cr
-5.23
Mar2022 ₹2,052 Cr -

Compare Revenue of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹14,668.3 Cr -2.8% -14.4% -3.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹440,278.0 Cr -3% -5.2% 17.9% Stock Analytics
DIVIS LABORATORIES ₹243,966.0 Cr 0.2% 9.7% 56.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹184,478.0 Cr 1.3% 2% 36.5% Stock Analytics
CIPLA ₹109,950.0 Cr -2.2% -6.6% -10.5% Stock Analytics
DR REDDYS LABORATORIES ₹95,967.4 Cr 1.4% -3.7% -8.8% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-2.8%

-14.4%

-3.2%

SENSEX

-2.8%

-5.2%

-8.4%


You may also like the below Video Courses